CORTEX PHARMACEUTIC Correlations
| PHXDelisted Stock | USD 4.35 0.00 0.00% |
The current 90-days correlation between CORTEX PHARMACEUTIC and Epsilon Energy is 0.12 (i.e., Average diversification). The correlation of CORTEX PHARMACEUTIC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
CORTEX PHARMACEUTIC Correlation With Market
Significant diversification
The correlation between CORTEX PHARMACEUTIC and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CORTEX PHARMACEUTIC and DJI in the same portfolio, assuming nothing else is changed.
CORTEX |
The ability to find closely correlated positions to CORTEX PHARMACEUTIC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CORTEX PHARMACEUTIC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CORTEX PHARMACEUTIC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CORTEX PHARMACEUTIC to buy it.
Moving together with CORTEX Stock
| 0.64 | 4ON | HEALTHCARE TRPFD | PairCorr |
| 0.77 | 9XJ | DETALION GAMES SA | PairCorr |
| 0.74 | 943 | FREY EO 250 | PairCorr |
| 0.64 | AO9 | BACKBONE Technology | PairCorr |
| 0.62 | PV6 | Pierre et Vacances | PairCorr |
| 0.61 | 0M7 | COFCO Joycome Foods | PairCorr |
Moving against CORTEX Stock
Related Correlations Analysis
| -0.5 | 0.66 | 0.53 | 0.44 | 0.72 | EPSN | ||
| -0.5 | -0.28 | -0.64 | -0.13 | -0.64 | PNRG | ||
| 0.66 | -0.28 | 0.66 | 0.19 | 0.64 | CRGY | ||
| 0.53 | -0.64 | 0.66 | -0.11 | 0.72 | EPM | ||
| 0.44 | -0.13 | 0.19 | -0.11 | 0.45 | BRN | ||
| 0.72 | -0.64 | 0.64 | 0.72 | 0.45 | MXC | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between CORTEX Stock performing well and CORTEX PHARMACEUTIC Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CORTEX PHARMACEUTIC's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| EPSN | 1.83 | (0.08) | (0.09) | (0.02) | 2.46 | 3.13 | 12.00 | |||
| PNRG | 3.08 | 0.27 | (0.01) | (0.64) | 3.86 | 5.55 | 26.53 | |||
| CRGY | 2.39 | 0.21 | (0.03) | (0.56) | 2.65 | 5.36 | 11.64 | |||
| EPM | 1.50 | 0.16 | 0.04 | 0.47 | 1.67 | 3.06 | 8.70 | |||
| BRN | 3.43 | (0.05) | 0.00 | 0.29 | 0.00 | 7.03 | 56.04 | |||
| MXC | 3.72 | 1.13 | 0.07 | (0.19) | 3.72 | 6.98 | 54.80 |
CORTEX PHARMACEUTIC Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CORTEX PHARMACEUTIC stock to make a market-neutral strategy. Peer analysis of CORTEX PHARMACEUTIC could also be used in its relative valuation, which is a method of valuing CORTEX PHARMACEUTIC by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
CORTEX PHARMACEUTIC Corporate Management
Elected by the shareholders, the CORTEX PHARMACEUTIC's board of directors comprises two types of representatives: CORTEX PHARMACEUTIC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CORTEX. The board's role is to monitor CORTEX PHARMACEUTIC's management team and ensure that shareholders' interests are well served. CORTEX PHARMACEUTIC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CORTEX PHARMACEUTIC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chad True | Principal Officer | Profile | |
| Taylor McClain | Vice Geology | Profile | |
| Glen Brown | Independent Director | Profile | |
| Stephanie Morris | Assistant Controller | Profile |
Still Interested in CORTEX PHARMACEUTIC?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.